Analysis of serum and urinal copper and zinc in Chinese northeast population with the prediabetes or diabetes with and without complications.

What Was Tested

The paper reports a study of Simvastatin, published as a clinical trial.

This study investigated the association of copper and zinc levels in the serum or urine of patients living in northeast China, with either prediabetes or diabetes.

In the T2D group, there were 24 patients with nephropathy, 34 with retinopathy, and 50 with peripheral neuropathy.

Who Took Part

The abstract describes 24 patients taking part.

PubMed indexes the participants as children, teenagers, young adults, adults, middle-aged adults and older adults, both men and women.

From January 2010 to October 2011, patients with type 1 diabetes (T1D, n = 25), type 2 diabetes (T2D, n = 137), impaired fasting glucose (IFG, n = 12) or impaired glucose tolerance (IGT, n = 15), and age/gender matched controls (n = 50) were enrolled.

What Was Measured

This study investigated the association of copper and zinc levels in the serum or urine of patients living in northeast China, with either prediabetes or diabetes.

Topics PubMed links to this paper include Asian People, China, Copper, Diabetes Mellitus, Type 1, Diabetes Mellitus, Type 2, Glycated Hemoglobin and Prediabetic State.

What This Means in Plain Language

This is a clinical trial of Simvastatin in 24 patients.

With fewer than 40 people, it is a small study, so it is better read as an early signal for further research than as a settled answer.

The publication is from 2013 (Oxidative medicine and cellular longevity), a journal based in United States.

More context: all human trials.